Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Fundamental Analysis

USA - NASDAQ:LFVN - US53222K2050 - Common Stock

8.54 USD
-0.27 (-3.06%)
Last: 10/20/2025, 8:00:02 PM
Fundamental Rating

7

Taking everything into account, LFVN scores 7 out of 10 in our fundamental rating. LFVN was compared to 33 industry peers in the Personal Care Products industry. LFVN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LFVN may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, LFVN could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year LFVN was profitable.
In the past year LFVN had a positive cash flow from operations.
In the past 5 years LFVN has always been profitable.
In the past 5 years LFVN always reported a positive cash flow from operatings.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

LFVN has a better Return On Assets (13.63%) than 90.91% of its industry peers.
LFVN has a Return On Equity of 28.30%. This is amongst the best in the industry. LFVN outperforms 93.94% of its industry peers.
LFVN's Return On Invested Capital of 20.12% is amongst the best of the industry. LFVN outperforms 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LFVN is in line with the industry average of 12.77%.
The last Return On Invested Capital (20.12%) for LFVN is above the 3 year average (11.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.63%
ROE 28.3%
ROIC 20.12%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200

1.3 Margins

Looking at the Profit Margin, with a value of 4.29%, LFVN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Profit Margin of LFVN has declined.
LFVN has a Operating Margin (5.34%) which is comparable to the rest of the industry.
LFVN's Operating Margin has declined in the last couple of years.
LFVN has a Gross Margin of 80.37%. This is amongst the best in the industry. LFVN outperforms 96.97% of its industry peers.
In the last couple of years the Gross Margin of LFVN has remained more or less at the same level.
Industry RankSector Rank
OM 5.34%
PM (TTM) 4.29%
GM 80.37%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. Health

2.1 Basic Checks

LFVN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LFVN has less shares outstanding
LFVN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.90 indicates that LFVN is not in any danger for bankruptcy at the moment.
LFVN has a better Altman-Z score (3.90) than 66.67% of its industry peers.
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.9
ROIC/WACC2.32
WACC8.66%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.87 indicates that LFVN should not have too much problems paying its short term obligations.
LFVN has a Current ratio (1.87) which is in line with its industry peers.
LFVN has a Quick Ratio of 1.11. This is a normal value and indicates that LFVN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of LFVN (1.11) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.11
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

LFVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.48%, which is quite impressive.
The Earnings Per Share has been decreasing by -1.70% on average over the past years.
The Revenue has grown by 14.17% in the past year. This is quite good.
The Revenue has been decreasing by -0.38% on average over the past years.
EPS 1Y (TTM)34.48%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%7.14%
Revenue 1Y (TTM)14.17%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%12.64%

3.2 Future

Based on estimates for the next years, LFVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.50% on average per year.
Based on estimates for the next years, LFVN will show a small growth in Revenue. The Revenue will grow by 3.53% on average per year.
EPS Next Y26.41%
EPS Next 2Y19.94%
EPS Next 3Y11.5%
EPS Next 5YN/A
Revenue Next Year4.02%
Revenue Next 2Y2.72%
Revenue Next 3Y3.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.95 indicates a reasonable valuation of LFVN.
84.85% of the companies in the same industry are more expensive than LFVN, based on the Price/Earnings ratio.
LFVN is valuated cheaply when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.66, which indicates a very decent valuation of LFVN.
LFVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LFVN is cheaper than 84.85% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LFVN to the average of the S&P500 Index (23.18), we can say LFVN is valued rather cheaply.
Industry RankSector Rank
PE 10.95
Fwd PE 8.66
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFVN indicates a rather cheap valuation: LFVN is cheaper than 84.85% of the companies listed in the same industry.
84.85% of the companies in the same industry are more expensive than LFVN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.31
EV/EBITDA 5.97
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

LFVN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LFVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y19.94%
EPS Next 3Y11.5%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.01%, LFVN has a reasonable but not impressive dividend return.
In the last 3 months the price of LFVN has falen by -37.71%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 5.87, LFVN pays a bit more dividend than its industry peers.
LFVN's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

LFVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

21.08% of the earnings are spent on dividend by LFVN. This is a low number and sustainable payout ratio.
DP21.08%
EPS Next 2Y19.94%
EPS Next 3Y11.5%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LIFEVANTAGE CORP

NASDAQ:LFVN (10/20/2025, 8:00:02 PM)

8.54

-0.27 (-3.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)10-29 2025-10-29
Inst Owners64.9%
Inst Owner Change0.02%
Ins Owners17.6%
Ins Owner Change1.03%
Market Cap108.37M
Analysts82.5
Price Target24.48 (186.65%)
Short Float %22.41%
Short Ratio16.12
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP21.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-08 2025-09-08 (0.045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.47%
Min EPS beat(2)-5.12%
Max EPS beat(2)56.07%
EPS beat(4)2
Avg EPS beat(4)27.69%
Min EPS beat(4)-5.12%
Max EPS beat(4)61.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.55%
Min Revenue beat(2)-6.06%
Max Revenue beat(2)-5.04%
Revenue beat(4)0
Avg Revenue beat(4)-4.89%
Min Revenue beat(4)-7.05%
Max Revenue beat(4)-1.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)8.82%
EPS NQ rev (3m)-11.9%
EPS NY rev (1m)-3.81%
EPS NY rev (3m)-3.81%
Revenue NQ rev (1m)2.53%
Revenue NQ rev (3m)-5.58%
Revenue NY rev (1m)-1.67%
Revenue NY rev (3m)-5.08%
Valuation
Industry RankSector Rank
PE 10.95
Fwd PE 8.66
P/S 0.47
P/FCF 10.31
P/OCF 9.12
P/B 3.13
P/tB 3.15
EV/EBITDA 5.97
EPS(TTM)0.78
EY9.13%
EPS(NY)0.99
Fwd EY11.55%
FCF(TTM)0.83
FCFY9.7%
OCF(TTM)0.94
OCFY10.96%
SpS18.01
BVpS2.73
TBVpS2.71
PEG (NY)0.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.63%
ROE 28.3%
ROCE 27.27%
ROIC 20.12%
ROICexc 36.69%
ROICexgc 37.06%
OM 5.34%
PM (TTM) 4.29%
GM 80.37%
FCFM 4.6%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
ROICexc(3y)21.53%
ROICexc(5y)26%
ROICexgc(3y)21.81%
ROICexgc(5y)26.49%
ROCE(3y)15.97%
ROCE(5y)19.54%
ROICexcg growth 3Y16.93%
ROICexcg growth 5Y-18.84%
ROICexc growth 3Y17.48%
ROICexc growth 5Y-17.77%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
F-Score8
Asset Turnover3.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.44%
Cap/Sales 0.6%
Interest Coverage 6099.5
Cash Conversion 77.36%
Profit Quality 107.16%
Current Ratio 1.87
Quick Ratio 1.11
Altman-Z 3.9
F-Score8
WACC8.66%
ROIC/WACC2.32
Cap/Depr(3y)63.96%
Cap/Depr(5y)69.38%
Cap/Sales(3y)1.05%
Cap/Sales(5y)1.12%
Profit Quality(3y)198.8%
Profit Quality(5y)180.19%
High Growth Momentum
Growth
EPS 1Y (TTM)34.48%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%7.14%
EPS Next Y26.41%
EPS Next 2Y19.94%
EPS Next 3Y11.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.17%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%12.64%
Revenue Next Year4.02%
Revenue Next 2Y2.72%
Revenue Next 3Y3.53%
Revenue Next 5YN/A
EBIT growth 1Y181.54%
EBIT growth 3Y17.09%
EBIT growth 5Y-4.68%
EBIT Next Year92.37%
EBIT Next 3Y19.32%
EBIT Next 5YN/A
FCF growth 1Y5.58%
FCF growth 3Y17.78%
FCF growth 5Y-7.66%
OCF growth 1Y-2.62%
OCF growth 3Y14.27%
OCF growth 5Y-8.31%